Australian Luxury Stock News

Index removals and why they matter for National Storage REIT National Storage REIT (ASX:NSR) has been removed from several major benchmarks, including the S&P/ASX 200, S&P/ASX 300, S&P/ASX All Ordinaries, S&P Global BMI, and S&P/ASX Small Ordinaries Index. For you as an investor, such broad index deletions can lead to portfolio reshuffles by index funds and some institutions. This may affect short term liquidity and trading volumes around the stock. See our latest analysis for National...

If you are wondering whether Alkane Resources at around A$1.60 is still offering value or has already priced in the story, you are asking the right question. The share price has had a mixed short term pattern, with an 11.6% decline over 7 days, an 8.8% gain over 30 days, and returns of 15.9% year to date and 113.3% over the past year. These moves sit against a backdrop of ongoing attention on rare earths and gold producers. Funding, project timelines, and permitting updates often influence...

GenusPlus Group recently announced it had secured an A$110 million lump-sum, turnkey contract to deliver engineering, procurement, construction and commissioning for the 200 MW/800 MWh Koolunga Battery Energy Storage System project in South Australia, with work underway and completion targeted by September 2027. This contract materially expands GenusPlus Group’s presence in battery energy storage infrastructure, reinforcing its role in Australia’s ongoing grid and renewable energy...

Treasury Wine Estates (ASX:TWE) has drawn fresh investor attention after announcing a shift to a regional operating model, along with senior management changes, following a share price jump of more than 16%. See our latest analysis for Treasury Wine Estates. The recent move to a regional operating model and the Convida brand launch have arrived after a challenging period, with the 1 year total shareholder return of 47.59% decline contrasting with the 27.12% 30 day share price return. This...

Clinuvel Pharmaceuticals recently reported that the European Medicines Agency issued final scientific advice on its planned pivotal Phase III CUV107 trial, outlining how SCENESSE (afamelanotide) will be evaluated as a systemic treatment for non-segmental vitiligo in adults and adolescents. The regulator’s “totality of evidence” approach, with T-VASI50 as the primary endpoint and strong emphasis on patient-reported and photographic outcomes, underscores both the complexity and patient-centric...

Bond offering brings PLS Group into focus PLS Group (ASX:PLS) has drawn fresh attention after announcing a US$600 million fixed income offering of 6.875% senior unsecured notes due 2031, issued under Regulation S and Rule 144A. See our latest analysis for PLS Group. The bond announcement lands after a strong run, with a 30-day share price return of 17.28% and year-to-date share price return of 33.87%. The 1-year total shareholder return is very large, hinting that momentum remains in focus...

Elevra Lithium (ASX:ELV) is back in focus after its March quarterly update highlighted improved execution at the North American Lithium operation, high plant utilization, stronger lithium recovery and record quarterly revenue of $81 million. See our latest analysis for Elevra Lithium. The share price has reacted strongly to the March update and the upcoming Q3 2026 results. A 1 month share price return of 52.02% has helped lift the 1 year total shareholder return to 322.46%, although the 3...

Adisyn follow on equity offering puts capital structure in focus Adisyn (ASX:AI1) has filed a follow on equity offering of A$14 million, issuing 207,407,407 ordinary shares at A$0.0675 each, a A$0.00405 discount per security via subsequent direct listing. See our latest analysis for Adisyn. The follow on offering comes after a period of sharp share price momentum, with Adisyn’s 30 day share price return of 300% and 1 year total shareholder return of 300% suggesting sentiment has recently...

Viva Energy Group Limited recently reported that total group sales volumes for the first quarter of 2026 reached 4,302 ML, up from 4,092 ML a year earlier. This increase in quarterly volumes highlights growing fuel demand across Viva Energy’s network and provides fresh insight into how its operations are tracking. We’ll now explore how this uplift in first-quarter sales volumes may influence Viva Energy Group’s investment narrative and outlook. The future of work is here. Discover the 35 top...

Fortescue shares after recent performance Fortescue (ASX:FMG) has come under pressure recently, with the share price showing a 5.7% decline over the past day and a 6.8% decline over the past week, catching the attention of investors. See our latest analysis for Fortescue. At the current share price of A$19.78, the recent 5.7% 1 day and 6.8% 7 day share price declines extend a weaker short term trend, even though the 1 year total shareholder return of 35.5% remains firmly positive. This mix of...

Cochlear (ASX:COH) is back in focus after the company cut its fiscal year profit guidance, citing softer demand in the US, surgical capacity constraints in Western Europe, and external risks in China and the Middle East. See our latest analysis for Cochlear. The steep guidance cut has been met with a sharp reset in sentiment, with a 7 day share price return of 42.21% decline and a 1 year total shareholder return of 62.47% decline pointing to fading momentum, even as management reiterates its...

Scentre Group has recently reported its Q1 2026 operating results and moved to refinance its balance sheet, including issuing $750 million in senior variable rate notes due 2032 and launching a cash tender offer for subordinated notes due 2080. By retiring long-dated subordinated debt and replacing it with new senior variable-rate funding, the Group is actively reshaping its debt profile and interest cost mix, which may influence perceptions of its financial flexibility and risk. We’ll now...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Sierra Nevada Gold...

Insiders who purchased Atomos Limited ( ASX:AMS ) shares in the past 12 months are unlikely to be deeply impacted by...

The analysts covering 29Metals Limited ( ASX:29M ) delivered a dose of negativity to shareholders today, by making a...

Intelligent Monitoring Group Limited ( ASX:IMB ) is possibly approaching a major achievement in its business, so we...

If you are wondering whether Woolworths Group at A$37.89 is offering good value or just pricing in a lot of optimism, you are not alone. The stock has returned 3.0% over the last week, 4.2% over the past month, 28.7% year to date and 23.6% over the last year, which naturally raises questions about what is already baked into the current price. Recent coverage has focused on Woolworths Group as a core consumer staples name on the ASX, with attention on how shoppers are responding to pricing,...

Whilst it may not be a huge deal, we thought it was good to see that the Solvar Limited ( ASX:SVR ) Independent...

While Eagers Automotive Limited ( ASX:APE ) might not have the largest market cap around , it saw a double-digit share...

Vulcan Energy Resources has reported that Germany’s State of Rhineland-Palatinate granted a five-year royalty exemption for lithium production until December 31, 2030, benefiting the company’s Lionheart integrated lithium and geothermal energy project currently under construction in the region. This exemption underscores government backing for domestic critical raw material supply chains, potentially enhancing the Lionheart Project’s economics by lowering costs on planned lithium hydroxide...

Commonwealth Bank of Australia is cutting 119 jobs, including roles at its Bankwest subsidiary. The roles include positions linked to automation projects, pointing to changes in how the bank structures its operations. The move affects staff and workflows across parts of the group’s banking operations. For investors tracking ASX:CBA, these job cuts come against a backdrop of multi year share price performance, with the stock currently at A$174.49 and returns of 94.6% over 3 years and 135.1%...

National Australia Bank recently disclosed that first-half credit impairment costs are expected to reach about A$706 million, roughly double prior levels, while also revising its software capitalisation policy so more technology spending will be expensed from the second half of 2026. To reinforce its capital position amid heightened global uncertainty surrounding the Iran war, NAB is offering a discounted, partially underwritten dividend reinvestment plan that could raise up to...

Alkane Resources (ASX:ALK) reports record quarterly gold equivalent production. The company generates strong operating cash flow in the same quarter. Alkane Resources is added to the S&P/ASX 200 Index, lifting its market profile. Alkane Resources, a gold producer listed on the ASX under the ticker ASX:ALK, has released an update that combines record quarterly output with solid cash generation. The company is now also included in the S&P/ASX 200 Index, which brings it into a broader group of...

Telix Pharmaceuticals recently announced several milestones, including the first patient dosed in the pivotal Phase 3 IPAX BrIGHT trial of TLX101-Tx for recurrent glioblastoma and the upcoming presentation of Phase 3 safety data for its prostate cancer therapy TLX591-Tx at the 2026 ASCO Annual Meeting. In parallel, Regeneron Pharmaceuticals and Telix entered a broad collaboration pairing Regeneron’s antibody portfolio with Telix’s radiopharmaceutical platform, potentially expanding Telix’s...